ANIP ANI Pharmaceuticals Inc

USD 56.87 -1.00 ( -1.73)%
Icon

ANI Pharmaceuticals Inc (ANIP) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 56.87

-1.00 (-1.73)%

USD 1.26B

0.25M

USD 86.50(+52.10%)

USD 60.00 (+5.50%)

Icon

ANIP

ANI Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 56.87
-1.00 ( -1.73)%
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.26B

USD 60.00 (+5.50%)

USD 56.87

ANI Pharmaceuticals Inc (ANIP) Stock Forecast

Show ratings and price targets of :
USD 86.50
(+52.10%)

Based on the ANI Pharmaceuticals Inc stock forecast from 3 analysts, the average analyst target price for ANI Pharmaceuticals Inc is USD 86.50 over the next 12 months. ANI Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of ANI Pharmaceuticals Inc is Neutral, which is based on 6 positive signals and 7 negative signals. At the last closing, ANI Pharmaceuticals Inc’s stock price was USD 56.87. ANI Pharmaceuticals Inc’s stock price has changed by -1.71% over the past week, -2.27% over the past month and +12.46% over the last year.

No recent analyst target price found for ANI Pharmaceuticals Inc
No recent average analyst rating found for ANI Pharmaceuticals Inc

Company Overview ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substanc...Read More

210 Main Street West, Baudette, MN, United States, 56623

642

December

USD

USA

Adjusted Closing Price for ANI Pharmaceuticals Inc (ANIP)

Loading...

Unadjusted Closing Price for ANI Pharmaceuticals Inc (ANIP)

Loading...

Share Trading Volume for ANI Pharmaceuticals Inc Shares

Loading...

Compare Performance of ANI Pharmaceuticals Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ANIP

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To ANI Pharmaceuticals Inc (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VTRS
Viatris Inc -0.20 (-1.52%) USD15.96B 225.00 12.42

Frequently Asked Questions About ANI Pharmaceuticals Inc (ANIP) Stock

Based on ratings from 3 analysts ANI Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 5 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on ANIP's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for ANIP is USD 86.50 over the next 12 months. The maximum analyst target price is USD 94 while the minimum anlayst target price is USD 60.

ANIP stock's Price/Earning ratio is 49.06. Our analysis grades ANIP stock's Price / Earning ratio at F. This means that ANIP stock's Price/Earning ratio is above 64% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSD exchange. Based on this ANIP may be a overvalued for its sector.

The last closing price of ANIP's stock was USD 56.87.

The most recent market capitalization for ANIP is USD 1.26B.

Based on targets from 3 analysts, the average taret price for ANIP is projected at USD 86.50 over the next 12 months. This means that ANIP's stock price may go up by +52.10% over the next 12 months.

We can't find any ETFs which contains ANI Pharmaceuticals Inc's stock.

As per our most recent records ANI Pharmaceuticals Inc has 642 Employees.

ANI Pharmaceuticals Inc's registered address is 210 Main Street West, Baudette, MN, United States, 56623. You can get more information about it from ANI Pharmaceuticals Inc's website at https://www.anipharmaceuticals.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About ANI Pharmaceuticals Inc (ANIP) Stock

Based on ratings from 3 analysts ANI Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 5 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on ANIP's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for ANIP is USD 86.50 over the next 12 months. The maximum analyst target price is USD 94 while the minimum anlayst target price is USD 60.

ANIP stock's Price/Earning ratio is 49.06. Our analysis grades ANIP stock's Price / Earning ratio at F. This means that ANIP stock's Price/Earning ratio is above 64% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSD exchange. Based on this ANIP may be a overvalued for its sector.

The last closing price of ANIP's stock was USD 56.87.

The most recent market capitalization for ANIP is USD 1.26B.

Based on targets from 3 analysts, the average taret price for ANIP is projected at USD 86.50 over the next 12 months. This means that ANIP's stock price may go up by +52.10% over the next 12 months.

We can't find any ETFs which contains ANI Pharmaceuticals Inc's stock.

As per our most recent records ANI Pharmaceuticals Inc has 642 Employees.

ANI Pharmaceuticals Inc's registered address is 210 Main Street West, Baudette, MN, United States, 56623. You can get more information about it from ANI Pharmaceuticals Inc's website at https://www.anipharmaceuticals.com.
Loading...